Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
OLMA
Stock Latest News
Company Announcements
Olema Pharmaceuticals Advances Phase 1 Study of OP-3136 for Advanced Tumors
2d ago
OLMA
Premium
Company Announcements
Olema Pharmaceuticals’ New Study on Advanced Breast Cancer Treatment: A Potential Game-Changer?
2d ago
OLMA
Premium
Company Announcements
Olema Pharmaceuticals’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
2d ago
OLMA
Premium
Ratings
Promising Outlook for Olema Pharmaceuticals: Buy Rating Driven by Palazestrant’s Potential in Breast Cancer Treatment
2d ago
OLMA
Premium
The Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
6d ago
OLMA
Premium
Company Announcements
Olema Pharmaceuticals Reports Positive Phase 1b/2 Trial Results
9d ago
8K
OLMA
Premium
The Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
9d ago
BA
DX
Premium
The Fly
Morning Movers: Cleveland-Cliffs surges following earnings report
9d ago
CLF
COO
Premium
Ratings
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ER+/HER- Metastatic Breast Cancer Treatment: An Analyst’s Buy Recommendation
9d ago
OLMA
Premium
The Fly
Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
9d ago
CHRO
OLMA
Premium
Ratings
Promising Efficacy and Safety of Olema Pharmaceuticals’ Palazestrant in Metastatic Breast Cancer Trials Supports Buy Rating
9d ago
OLMA
Premium
The Fly
Olema announces updated data on Phase 1b/2 study of palazestrant, ribociclib
10d ago
OLMA
Premium
The Fly
Olema Oncology initiated with a Buy at Guggenheim
21d ago
OLMA
Premium
Ratings
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ESR1 Patient Treatment Drives Buy Rating
1M ago
OLMA
Premium
The Fly
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
1M ago
CHRO
OLMA
Premium
The Fly
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
1M ago
CHRO
OLMA
Premium
Ratings
Olema Pharmaceuticals: Strategic Positioning and Promising Outlook in the Oral SERD Market
1M ago
OLMA
Premium
The Fly
Oppenheimer says Olema collaboration with Pfizer could lead to bidding war
2M ago
NVS
PFE
Premium
Ratings
Buy Recommendation for Olema Pharmaceuticals Driven by Strategic Collaborations and Promising Clinical Developments
2M ago
OLMA
Premium
Ratings
Strategic Collaboration with Pfizer Boosts Olema Pharmaceuticals’ Prospects in ER+ Breast Cancer Treatment
2M ago
OLMA
Premium
Company Announcements
Olema Pharmaceuticals Partners with Pfizer for New Trial
2M ago
8K
OLMA
Premium
The Fly
Olema Oncology announces new trial agreement with Pfizer
2M ago
PFE
OLMA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.